Greenfield Seitz Capital Management, LLC Abbott Laboratories Transaction History
Greenfield Seitz Capital Management, LLC
- $310 Billion
- Q3 2025
A detailed history of Greenfield Seitz Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Greenfield Seitz Capital Management, LLC holds 2,740 shares of ABT stock, worth $356,282. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,740
Previous 2,740
-0.0%
Holding current value
$356,282
Previous $373 Million
1.52%
% of portfolio
0.12%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,651Shares Held
1.38BCall Options Held
10.4MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...